EDIT vs NIO · rev $32.3M vs rev $12.51B
Editas Medicine Inc (EDIT) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
EDIT currently screens at market cap $375.2M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the EDIT and NIO stock pages for the full models.
Not investment advice.